St. Patrick's Day may have come and gone for this year, but the analysts at biotech boutique shop Leerink have highlighted six Ireland-based firms that could be tempting takeover targets for large…
After a very long run in the market from the 2009 lows, there is always the chance a healthy correction is right around the corner. Here are six stocks that Cantor Fitzgerald…
The biotech and specialty pharmaceutical groups got hit hard Thursday for a variety of reasons. The largest of which the analysts at Jefferies believe, is commentary within Washington's new budget proposal regarding…
Analysts at at Merrill Lynch see 2014 as a promising year for biotech mergers and acquisitions. A new research report shows which companies they believe will make acquisitions or which will be…
Teva Pharmaceutical resume a deal-making strategy that made it one of the most acquisitive drug companies of the past decade. Could one of these biotech takeover candidates be the next target?
Jon OggThis week marks the last one of major earnings reports, and both the DJIA and S&P 500 Index have recently challenged new all-time highs. Investors and traders have to wonder which stocks…
ThinkstockBiotech and certain aspects of the health care and life sciences sector can often see incredible surges from day to day. The group can also witness many implosions on bad news as…
August 8, 2013: U.S. equity markets opened higher this morning after China reported that its trade surplus narrowed to $17.1 billion in July, well below an expected surplus of $27.2 billion. Elsewhere…
Investors and traders have seen three days of selling now and might want to consider looking for stock bargains in the malaise. 24/7 Wall St. reviews many fresh research calls each morning…
August 7, 2013: U.S. equity markets opened lower this morning after more comments by Fed officials point toward a winding down of the central bank’s stimulus sooner rather than later. In Europe,…
These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Wednesday, August 7, 2013. They include CVS Caremark, DaVita Healthcare, Zillow and Marathon Oil.
ThinkstockEven the best firms on Wall Street sometimes lose their analysts, and when that happens they are forced to suspend their coverage on stocks until they can replace the talent. Oppenheimer has…
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise is the difference…
U.S. equity markets opened slightly lower this morning, even though the report on new U.S. claims for unemployment benefits came in a bit lower than expected. The drag on stock prices followed…
These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Thursday, June 6, 2013. They include Barnes & Noble, Vera Bradley and Coldwater Creek.
